ESC 365 - The effectiveness of allopurinol in improving ischemic symptoms or exercise tolerance in patients with chronic coronary syndromes: a systematic review and meta-analysis of randomized clinical trials

ESC Professional Premium Access

The effectiveness of allopurinol in improving ischemic symptoms or exercise tolerance in patients with chronic coronary syndromes: a systematic review and meta-analysis of randomized clinical trials

Session: New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease

Topic: Chronic Ischaemia

Speaker: Doctor S. Del Vecchio Ziotti (Sao Paulo, BR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Sara Del Vecchio Ziotti

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

0 follower

6 more presentations in this session

Discussant - Expanding pharmacological and non-pharmacological options for coronary disease

Impact of nebivolol versus carvedilol on long-term clinical outcomes in STEMI patients treated with drug-eluting stents

Baseline characteristics, treatment and mortality among acute myocardial infarction patients with varying left ventricular ejection fractions according to the Estonian Myocardial Infarction Registry

Speaker: Ms J. Smirnova (Tallinn, EE)

Preliminary experience with comprehensive treatment in patients with rapidly progressive coronary artery disease (RP-CAD)

Speaker: Doctor Y. Liu (Beijing, CN)

Intensified hypolipidaemic therapy with inclisiran for atherosclerotic plaque stabilization

Speaker: Doctor B. Kokina (Riga, LV)

Access the full session

New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease

Speakers: Doctor S. Del Vecchio Ziotti, Ms J. Smirnova, Doctor Y. Liu, Doctor B. Kokina

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources